{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:21:27Z","timestamp":1791037287514,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002581","name":"School of Medicine, CHA University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.carpath.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:21:20Z","timestamp":1562959280000},"page":"107139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy"],"prefix":"10.1016","volume":"43","author":[{"given":"Prakash","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-Raman","family":"Purushothaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meerarani","family":"Purushothaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Purushottam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro R.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2019.06.003_bb0005","first-page":"e38","article-title":"Heart disease and stroke Statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0010","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.jacc.2011.08.023","volume":"58","author":"Rooke","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.carpath.2019.06.003_bb0015","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic inter-society consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.carpath.2019.06.003_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0034-1393964","article-title":"Clinical assessment of patients with peripheral arterial disease","volume":"31","author":"Bailey","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.carpath.2019.06.003_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0039-6109(05)70327-3","article-title":"Mediators of restenosis","volume":"78","author":"Kagan","year":"1998","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.carpath.2019.06.003_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvt115","article-title":"Biological responses in stented arteries","volume":"99","author":"Chaabane","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2019.06.003_bb0035","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/CIRCULATIONAHA.115.017364","article-title":"Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) trial","volume":"132","author":"Krankenberg","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0040","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1073\/pnas.90.20.9552","article-title":"Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations","volume":"90","author":"Jordan","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.carpath.2019.06.003_bb0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/heart.89.2.218","article-title":"In-stent stenosis: pathology and implications for the development of drug eluting stents","volume":"89","author":"Bennett","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.carpath.2019.06.003_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carpath.2019.06.003_bb0060","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of Femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2016.06.046","article-title":"Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: implications in the progression of human peripheral artery restenosis","volume":"251","author":"Krishnan","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carpath.2019.06.003_bb0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jacc.2012.04.011","article-title":"Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis","volume":"60","author":"Purushothaman","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.carpath.2019.06.003_bb0075","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.amjcard.2016.01.006","article-title":"Relation of internal elastic lamellar layer disruption to neointimal cellular proliferation and type III collagen deposition in human peripheral artery restenosis","volume":"117","author":"Krishnan","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carpath.2019.06.003_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1358863X11402249","article-title":"Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic atherosclerosis","volume":"16","author":"Purushothaman","year":"2011","journal-title":"Vasc Med"},{"key":"10.1016\/j.carpath.2019.06.003_bb0085","first-page":"2113","article-title":"Drug-coated balloon treatment for Femoropopliteal artery disease","volume":"10","author":"Brodmann","year":"2017","journal-title":"The INPACT Global Study De Novo In-Stent Restenosis Imaging Cohort JACC Cardiovasc Interv"},{"key":"10.1016\/j.carpath.2019.06.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carpath.2019.06.003_bb0095","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.CIR.79.6.1374","article-title":"Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia","volume":"79","author":"Liu","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0100","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/01.CIR.95.8.1998","article-title":"Histopathology of in-stent restenosis in patients with peripheral artery disease","volume":"95","author":"Kearney","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.108.3.815","article-title":"Proliferative activity in coronary atherectomy tissue. Clinical, histopathologic, and immunohistochemical correlates","volume":"108","author":"Taylor","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.carpath.2019.06.003_bb0110","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/01.CIR.0000041632.02514.14","article-title":"Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans","volume":"106","author":"Virmani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0115","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.CIR.0000139337.56084.30","article-title":"Extracellular matrix changes in stented human coronary arteries","volume":"110","author":"Farb","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2019.06.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082456","article-title":"Decorin mimic inhibits vascular smooth muscle proliferation and migration","volume":"8","author":"Scott","year":"2013","journal-title":"PLoS One"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880719300985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880719300985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:44:45Z","timestamp":1760960685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880719300985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":24,"alternative-id":["S1054880719300985"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2019.06.003","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107139"}}